Twitter Feed
@travisthetechie ("Travis Smith") retweeted:
@rrelyea ("Rob Relyea") wrote:
Exciting news for immunocompromised: Evusheld long lasting monoclonal antibody injection has been authorized by FDA.
with quote tweet:
@JohnPLeonardMD ("John P. Leonard, MD") wrote:
For immunocompromised patients: Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19 https://www.astrazeneca.com/media-centre/press-releases/2021/evusheld-long-acting-antibody-combination-authorised-for-emergency-use-in-the-us-for-pre-exposure-prophylaxis-prevention-of-covid-19.html